C-RAD has signed a premium service agreement with a major healthcare provider on the U.S. East Coast, strengthening a longstanding partnership.
Valued at approximately SEK8m ($0.8m), the multi-year contract aims to enhance continuity, efficiency, and precision within the provider’s radiation oncology programme.
The agreement, finalised and recorded in the second quarter, includes the use of multiple Catalyst+ HD and Sentinel 4DCT systems.
It represents a strategic initiative to streamline service management and ensure the sustained performance of these systems.
C-RAD president and CEO Cecilia de Leeuw said: “This important partnership demonstrates the provider’s continued confidence in C-RAD’s technology and our team.
“It underscores the long-term value of our solutions and our ability to deliver consistent, high-quality support. We look forward to deepening our collaboration and helping clinicians advance the standard of care in radiation therapy.”
The agreement highlights C-RAD’s ongoing commitment to expanding its presence in the US market. The company remains dedicated to its mission of improving cancer treatment outcomes through innovative and patient-focused technologies.
C-RAD continues to deliver clinically validated solutions that enhance precision, workflow efficiency, and safety in radiotherapy.
The company specialises in surface-guided imaging solutions for radiation therapy, which enable precise dose delivery to tumours while safeguarding healthy tissue from unnecessary exposure.
C-RAD employs high-speed 3D cameras and augmented reality to support initial patient setup and monitor motion during treatment. This approach ensures workflow efficiency and accuracy without the need for tattoos or additional imaging doses, prioritising patient safety and comfort.
